{
  "docId": "019dd923-622b-71dc-a6db-81a8a09bae5a",
  "docSlug": "1bbbc8a9f010",
  "documentTitle": "Solventum Corporation (SOLV)",
  "authorId": "06_Trian_Partners",
  "authorName": "Trian Fund Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2025-01-08 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 5,
  "pageCount": 25,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "executive_summary",
  "function": "diagnose_problem",
  "density": "dense",
  "nDataPoints": 10,
  "notes": "This is a text-heavy slide from an activist investor deck (Trian Partners) detailing the investment thesis and subsequent disappointment regarding Solventum.",
  "elementsJson": [
    "paragraph",
    "quote_block"
  ],
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622b-71dc-a6db-81a8a09bae5a/5",
  "deckHref": "/decks/019dd923-622b-71dc-a6db-81a8a09bae5a",
  "deckJsonHref": "/decks/019dd923-622b-71dc-a6db-81a8a09bae5a.json",
  "deckAnchorHref": "/decks/019dd923-622b-71dc-a6db-81a8a09bae5a#slide-5",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Unfortunately for shareholders, Solventum's performance since the spin has not lived up to its promise.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-ee38-728b-98c2-f10211502cbf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.8,
        "x": 0.1,
        "y": 0.05
      },
      "kind": "paragraph",
      "text": "Having followed 3M for many years, we have long admired its health care business... Solventum has greater opportunities to drive performance improvements as a standalone company than most spins in recent memory.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1c9fddf1-fa69-429d-aff1-1cfa7a9dec3f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.8,
        "x": 0.1,
        "y": 0.62
      },
      "kind": "paragraph",
      "text": "Unfortunately for shareholders, Solventum's performance since the spin has not lived up to its promise... Consensus estimates project less than 1% revenue growth and margins flatlining at 20% - both at historic lows.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ea3b1fc0-bf46-4f46-8d40-8fac42609d25",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.15,
        "y": 0.33
      },
      "kind": "quote",
      "text": "So there are a lot of benefits of separation. It really does allow a level of focus and a level of scrutiny in specific areas that you might not have as part of a broader conglomerate.",
      "attrs": null,
      "subkind": "pull-quote",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0aa95944-3891-4ff6-aed7-e6d6e0dd6f5d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "So there are a lot of benefits of separation. It really does allow a level of focus and a level of scrutiny in specific areas that you might not have as part of a broader conglomerate. And furthermore, we really get to optimize things for us specifically versus a broader organization. And so part of the reason we're going to be able to expand margin are some of the benefits of becoming a stand-alone company. — GE HealthCare",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-ee38-728b-98c2-f7bbdfa73cf6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.1,
        "y": 0.58
      },
      "kind": "title",
      "text": "Solventum Has Not Lived Up to its Potential",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "269b47fd-67ed-4045-aac6-6d379ca0c75c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "1a6d1139-373b-40a2-a6c6-e88dddbd7938",
      "evidence": "The slide is addressed to shareholders and analysts, indicating a clear audience definition.",
      "confidence": 0.7
    },
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "36441899-20ec-4014-9405-3b82abaf7c18",
      "evidence": "This slide serves as a summary of the key points, providing an overview of the situation with Solventum.",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "breakup-spinoff",
      "slug": null,
      "matchId": "4285a3f0-46c0-4694-ae52-d402a9c3e6aa",
      "evidence": "Analysis of 3M Health Care spin-off performance and potential",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 5,
      "from": 2,
      "beatId": "02c21229-e904-4b66-a230-854917fc7ed8",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem (Identify pain)",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "Slides 2-5 highlight Solventum's underperformance and decline in performance since spinning out of 3M.",
      "position": 0,
      "confidence": 0.9,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 23,
      "from": 2,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "06cc74da-b5d0-4b02-be5e-0e77cc27e506",
      "evidence": "The deck emphasizes the need for change to restore Solventum's performance and unlock shareholder value.",
      "position": 0,
      "objective": "The cost of inaction is a decline in shareholder value.",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.8,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}